Christopher James1,2, Johnny Millar3,4, Stephen Horton4,5, Christian Brizard6, Charlotte Molesworth4, Warwick Butt3,4,7. 1. Department of Intensive Care, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. Christopher.James@rch.org.au. 2. Murdoch Children's Research Institute, Melbourne, Australia. Christopher.James@rch.org.au. 3. Department of Intensive Care, Royal Children's Hospital, 50 Flemington Road, Parkville, Melbourne, VIC, 3052, Australia. 4. Murdoch Children's Research Institute, Melbourne, Australia. 5. Perfusion Department, Royal Children's Hospital, Melbourne, Australia. 6. Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia. 7. Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Abstract
PURPOSE:Cardiopulmonary bypass induces an ischaemia-reperfusion injury and systemic inflammatory response, which contributes to low cardiac output syndrome following cardiac surgery. Exogenous nitric oxide during cardiopulmonary bypass has shown potential to ameliorate such injury. We undertook a large randomised controlled trial to investigate the clinical effects of administering nitric oxide to the cardiopulmonary bypass circuit in children. METHODS: After written informed consent, children were randomised to receive 20 ppm nitric oxide to the gas inflow of the cardiopulmonary bypass oxygenator, or standard conduct of bypass. RESULTS:101 children receivednitric oxide and developed low cardiac output syndrome less frequently (15 vs. 31 %, p = 0.007) than the 97 children who did not receive nitric oxide. This effect was most marked in children aged less than 6 weeks of age (20 vs. 52 %, p = 0.012) and in those aged 6 weeks to 2 years (6 vs. 24 %, p = 0.026), who also had significantly reduced ICU length of stay (43 vs. 84 h, p = 0.031). Low cardiac output syndrome was less frequent following more complex surgeries if nitric oxide was administered (17 vs. 48 %, p = 0.018). ECMO was used less often in the nitric oxide group (1 vs. 8 %, p = 0.014). CONCLUSIONS: Delivery of nitric oxide to the oxygenator gas flow during paediatric cardiopulmonary bypass reduced the incidence of low cardiac output syndrome by varying degrees, according to age group and surgery complexity. CLINICAL TRIAL REGISTRATION: ACTRN12615001376538.
RCT Entities:
PURPOSE: Cardiopulmonary bypass induces an ischaemia-reperfusion injury and systemic inflammatory response, which contributes to low cardiac output syndrome following cardiac surgery. Exogenous nitric oxide during cardiopulmonary bypass has shown potential to ameliorate such injury. We undertook a large randomised controlled trial to investigate the clinical effects of administering nitric oxide to the cardiopulmonary bypass circuit in children. METHODS: After written informed consent, children were randomised to receive 20 ppm nitric oxide to the gas inflow of the cardiopulmonary bypass oxygenator, or standard conduct of bypass. RESULTS: 101 children received nitric oxide and developed low cardiac output syndrome less frequently (15 vs. 31 %, p = 0.007) than the 97 children who did not receive nitric oxide. This effect was most marked in children aged less than 6 weeks of age (20 vs. 52 %, p = 0.012) and in those aged 6 weeks to 2 years (6 vs. 24 %, p = 0.026), who also had significantly reduced ICU length of stay (43 vs. 84 h, p = 0.031). Low cardiac output syndrome was less frequent following more complex surgeries if nitric oxide was administered (17 vs. 48 %, p = 0.018). ECMO was used less often in the nitric oxide group (1 vs. 8 %, p = 0.014). CONCLUSIONS: Delivery of nitric oxide to the oxygenator gas flow during paediatric cardiopulmonary bypass reduced the incidence of low cardiac output syndrome by varying degrees, according to age group and surgery complexity. CLINICAL TRIAL REGISTRATION: ACTRN12615001376538.
Authors: L Comini; T Bachetti; L Agnoletti; G Gaia; S Curello; B Milanesi; M Volterrani; G Parrinello; C Ceconi; A Giordano; A Corti; R Ferrari Journal: Eur Heart J Date: 1999-10 Impact factor: 29.983
Authors: Yasuko Nagasaka; Bernadette O Fernandez; Maria F Garcia-Saura; Bodil Petersen; Fumito Ichinose; Kenneth D Bloch; Martin Feelisch; Warren M Zapol Journal: Anesthesiology Date: 2008-10 Impact factor: 7.892
Authors: Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch Journal: Pediatr Crit Care Med Date: 2010-03 Impact factor: 3.624
Authors: John D Lang; Alvin B Smith; Angela Brandon; Kelley M Bradley; Yuliang Liu; Wei Li; D Ralph Crowe; Nirag C Jhala; Richard C Cross; Luc Frenette; Kenneth Martay; Youri L Vater; Alexander A Vitin; Gregory A Dembo; Derek A Dubay; J Steven Bynon; Jeff M Szychowski; Jorge D Reyes; Jeffrey B Halldorson; Stephen C Rayhill; Andre A Dick; Ramasamy Bakthavatsalam; Jared Brandenberger; Jo Ann Broeckel-Elrod; Laura Sissons-Ross; Terry Jordan; Lucinda Y Chen; Arunotai Siriussawakul; Devin E Eckhoff; Rakesh P Patel Journal: PLoS One Date: 2014-02-12 Impact factor: 3.240
Authors: Mark J Peters; Andrew Argent; Marino Festa; Stéphane Leteurtre; Jefferson Piva; Ann Thompson; Douglas Willson; Pierre Tissières; Marisa Tucci; Jacques Lacroix Journal: Intensive Care Med Date: 2017-03-17 Impact factor: 17.440
Authors: Martin Bennett; Clarke Thuys; Simon Augustin; Brad Schultz; Steve Bottrell; Alison Horton; Andrzej Bednarz; Steve Horton Journal: J Extra Corpor Technol Date: 2018-12
Authors: Yu Qin; Joanna Zajda; Elizabeth J Brisbois; Hang Ren; John M Toomasian; Terry C Major; Alvaro Rojas-Pena; Benjamin Carr; Thomas Johnson; Jonathan W Haft; Robert H Bartlett; Andrew P Hunt; Nicolai Lehnert; Mark E Meyerhoff Journal: Mol Pharm Date: 2017-10-25 Impact factor: 4.939